308 related articles for article (PubMed ID: 8383219)
1. Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles.
Rose RC; Bonnez W; Reichman RC; Garcea RL
J Virol; 1993 Apr; 67(4):1936-44. PubMed ID: 8383219
[TBL] [Abstract][Full Text] [Related]
2. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.
Kirnbauer R; Booy F; Cheng N; Lowy DR; Schiller JT
Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12180-4. PubMed ID: 1334560
[TBL] [Abstract][Full Text] [Related]
3. The L1 major capsid protein of human papillomavirus type 16 variants affects yield of virus-like particles produced in an insect cell expression system.
Touze A; El Mehdaoui S; Sizaret PY; Mougin C; Muñoz N; Coursaget P
J Clin Microbiol; 1998 Jul; 36(7):2046-51. PubMed ID: 9650960
[TBL] [Abstract][Full Text] [Related]
4. Self-assembly of human papillomavirus type 16 capsids by expression of the L1 protein in insect cells.
Le Cann P; Coursaget P; Iochmann S; Touze A
FEMS Microbiol Lett; 1994 Apr; 117(3):269-74. PubMed ID: 8200503
[TBL] [Abstract][Full Text] [Related]
5. Detection of antibodies against human papillomavirus (HPV) type 16 virions by enzyme-linked immunosorbent assay using recombinant HPV 16 L1 capsids produced by recombinant baculovirus.
Le Cann P; Touze A; Enogat N; Leboulleux D; Mougin C; Legrand MC; Calvet C; Afoutou JM; Coursaget P
J Clin Microbiol; 1995 May; 33(5):1380-2. PubMed ID: 7615761
[TBL] [Abstract][Full Text] [Related]
6. Mutant canine oral papillomavirus L1 capsid proteins which form virus-like particles but lack native conformational epitopes.
Chen Y; Ghim SJ; Jenson AB; Schlegel R
J Gen Virol; 1998 Sep; 79 ( Pt 9)():2137-46. PubMed ID: 9747722
[TBL] [Abstract][Full Text] [Related]
7. Quantitative disassembly and reassembly of human papillomavirus type 11 viruslike particles in vitro.
McCarthy MP; White WI; Palmer-Hill F; Koenig S; Suzich JA
J Virol; 1998 Jan; 72(1):32-41. PubMed ID: 9420197
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus type 16 E6, E7 and L1 and type 18 E7 proteins produced by recombinant baculoviruses.
Park DS; Selvey LA; Kelsall SR; Frazer IH
J Virol Methods; 1993 Dec; 45(3):303-18. PubMed ID: 8106603
[TBL] [Abstract][Full Text] [Related]
9. Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16.
Varsani A; Williamson AL; de Villiers D; Becker I; Christensen ND; Rybicki EP
J Virol; 2003 Aug; 77(15):8386-93. PubMed ID: 12857908
[TBL] [Abstract][Full Text] [Related]
10. Yeast coexpression of human papillomavirus types 6 and 16 capsid proteins.
Buonamassa DT; Greer CE; Capo S; Yen TS; Galeotti CL; Bensi G
Virology; 2002 Feb; 293(2):335-44. PubMed ID: 11886254
[TBL] [Abstract][Full Text] [Related]
11. Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types.
Christensen ND; Cladel NM; Reed CA; Budgeon LR; Embers ME; Skulsky DM; McClements WL; Ludmerer SW; Jansen KU
Virology; 2001 Dec; 291(2):324-34. PubMed ID: 11878901
[TBL] [Abstract][Full Text] [Related]
12. Expression of human papillomavirus type 6 L1 and L2 isolated in China and self assembly of virus-like particles by the products.
Wang M; Wang LL; Chen LF; Han YH; Zou YH; Si JY; Song GX
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Jan; 35(1):27-34. PubMed ID: 12518224
[TBL] [Abstract][Full Text] [Related]
13. Production of human papillomavirus type 33 L1 major capsid protein and virus-like particles from Bacillus subtilis to develop a prophylactic vaccine against cervical cancer.
Baek JO; Seo JW; Kwon O; Park SM; Kim CH; Kim IH
Enzyme Microb Technol; 2012 Mar; 50(3):173-80. PubMed ID: 22305172
[TBL] [Abstract][Full Text] [Related]
14. Self-assembly, antigenicity, and immunogenicity of the rabbit haemorrhagic disease virus (Czechoslovakian strain V-351) capsid protein expressed in baculovirus.
Nagesha HS; Wang LF; Hyatt AD; Morrissy CJ; Lenghaus C; Westbury HA
Arch Virol; 1995; 140(6):1095-1108. PubMed ID: 7541982
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus type 16 capsid proteins produced from recombinant Semliki Forest virus assemble into virus-like particles.
Heino P; Dillner J; Schwartz S
Virology; 1995 Dec; 214(2):349-59. PubMed ID: 8553535
[TBL] [Abstract][Full Text] [Related]
16. Generation and neutralization of pseudovirions of human papillomavirus type 33.
Unckell F; Streeck RE; Sapp M
J Virol; 1997 Apr; 71(4):2934-9. PubMed ID: 9060652
[TBL] [Abstract][Full Text] [Related]
17. Immunological analyses of human papillomavirus capsids.
Giroglou T; Sapp M; Lane C; Fligge C; Christensen ND; Streeck RE; Rose RC
Vaccine; 2001 Feb; 19(13-14):1783-93. PubMed ID: 11166904
[TBL] [Abstract][Full Text] [Related]
18. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
[TBL] [Abstract][Full Text] [Related]
19. Type-specific and cross-reactive antibodies induced by human papillomavirus 31 L1/L2 virus-like particles.
Xu Y; Wang Q; Han Y; Song G; Xu X
J Med Microbiol; 2007 Jul; 56(Pt 7):907-913. PubMed ID: 17577054
[TBL] [Abstract][Full Text] [Related]
20. Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies.
Christensen ND; Dillner J; Eklund C; Carter JJ; Wipf GC; Reed CA; Cladel NM; Galloway DA
Virology; 1996 Sep; 223(1):174-84. PubMed ID: 8806551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]